ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION

ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION

Detalhes bibliográficos
Principais autores:	Collins, R, Peto, R, Sleight, P
Formato:	Journal article
Publicado em:	1989

Registros relacionados

RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
por: Collins, R, et al.
Publicado em: (1987)

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
por: Baigent, C, et al.
Publicado em: (1998)

Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
por: Collins, R
Publicado em: (1987)

RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
por: Collins, R
Publicado em: (1987)

INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
por: Stampfer, M, et al.
Publicado em: (1983)

Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
por: Alexopoulos, D, et al.
Publicado em: (1991)

Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials.
por: Stampfer, M, et al.
Publicado em: (1982)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
por: Collins, R, et al.
Publicado em: (1997)

MORNING PEAK IN THE INCIDENCE OF MYOCARDIAL-INFARCTION - EXPERIENCE IN THE ISIS-2 TRIAL
por: Willich, S, et al.
Publicado em: (1992)

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
por: Hunt, D, et al.
Publicado em: (1992)

Side Effects of Intravenous Streptokinase in Different Age Groups Patients with Acute Myocardial Infarction
por: M Behnam Moghadam, et al.
Publicado em: (2014-02-01)

ISIS COLLABORATIVE GROUP - RANDOMIZED TRIAL OF EARLY IV ATENOLOL IN MYOCARDIAL-INFARCTION - SUBSIDIARY ANALYSES
por: Sleight, P, et al.
Publicado em: (1986)

ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
por: Collins, R, et al.
Publicado em: (1993)

Early intravenous atenolol treatment in suspected acute myocardial infarction.
por: Sleight, P, et al.
Publicado em: (1981)

RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE
por: Candelise, L, et al.
Publicado em: (1995)

Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.
por: Collins, R, et al.
Publicado em: (1988)

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
por: Collins, R, et al.
Publicado em: (1995)

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
por: White, H, et al.
Publicado em: (1997)

Hemarthrosis of the knees following streptokinase therapy for acute myocardial infarction
por: Pimenta Eduardo, et al.
Publicado em: (2003-01-01)

Early intravenous beta-blockade in myocardial infarction.
por: Sleight, P, et al.
Publicado em: (1982)

ISIS-4 - REPLY
por: Collins, R, et al.
Publicado em: (1995)

Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction
por: V. A. Stolyarov, et al.
Publicado em: (2005-04-01)

In-Hospital Outcome of patients having Acute Myocardial Infarction with and without Streptokinase
por: Shimal Khan, et al.
Publicado em: (2009-12-01)

Beta blockade during and after myocardial infarction: an overview of the randomized trials.
por: Yusuf, S, et al.
Publicado em: (1985)

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
por: Yusuf, S, et al.
Publicado em: (1988)

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.
por: Teo, K, et al.
Publicado em: (1991)

OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION
por: Sleight, P, et al.
Publicado em: (1986)

Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.
por: Yusuf, S, et al.
Publicado em: (1980)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
por: Mojtaba Salarifar, et al.
Publicado em: (2009-01-01)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
por: Navid Paydari, et al.
Publicado em: (2009-03-01)

AFTER ISIS-3 - REPLY
por: Collins, R, et al.
Publicado em: (1992)

RANDOMIZED CONTROLLED TRIAL OF ORAL CAPTOPRIL, OF ORAL ISOSORBIDE MONONITRATE AND OF INTRAVENOUS MAGNESIUM-SULFATE STARTED EARLY IN ACUTE MYOCARDIAL-INFARCTION - SAFETY AND HEMODYNAMIC-EFFECTS
por: Flather, M, et al.
Publicado em: (1994)

Clinical predictors of successful thrombolysis with streptokinase and possible circadian periodicity in Acute Myocardial Infarction
por: R. Balamurugan, et al.
Publicado em: (2014-11-01)

REDUCTION IN INFARCT SIZE, ARRHYTHMIAS, CHEST PAIN AND MORBIDITY BY EARLY INTRAVENOUS BETA-BLOCKADE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION
por: Yusuf, S, et al.
Publicado em: (1983)

Magnesium in acute myocardial infarction.
por: Collins, R, et al.
Publicado em: (1997)

REDUCTION IN INFARCT SIZE, ARRHYTHMIAS AND CHEST PAIN BY EARLY INTRAVENOUS BETA-BLOCKADE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION
por: Yusuf, S, et al.
Publicado em: (1983)

Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
por: Yusuf, S, et al.
Publicado em: (1983)

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
por: Chen, Z, et al.
Publicado em: (2005)

Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
por: Flather, M, et al.
Publicado em: (1994)

The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction
por: Ya. L. Gabinsky, et al.
Publicado em: (2006-12-01)